المؤلفون: Sarno F., Benincasa G., List M., Barabasi A. -L., Baumbach J., Ciardiello F., Filetti S., Glass K., Loscalzo J., Marchese C., Maron B. A., Paci P., Parini P., Petrillo E., Silverman E. K., Verrienti A., Altucci L., Napoli C.

المساهمون: Sarno, F., Benincasa, G., List, M., Barabasi, A. -L., Baumbach, J., Ciardiello, F., Filetti, S., Glass, K., Loscalzo, J., Marchese, C., Maron, B. A., Paci, P., Parini, P., Petrillo, E., Silverman, E. K., Verrienti, A., Altucci, L., Napoli, C.

مصطلحات موضوعية: algorithm, cancer, CVD, epi-drug, epigenetic, network medicine, precision medicine

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33785068; info:eu-repo/semantics/altIdentifier/wos/WOS:000636238100001; volume:13; issue:1; firstpage:66; lastpage:103; numberofpages:38; journal:CLINICAL EPIGENETICS; http://hdl.handle.net/11573/1568674Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103380934

الإتاحة: https://doi.org/10.1186/s13148-021-01047-zTest
http://hdl.handle.net/11573/1568674Test

المؤلفون: Capasso A., Benigni A., Capitanio U., Danesh F. R., Di Marzo V., Gesualdo L., Grandaliano G., Jaimes E. A., Malyszko J., Perazella M. A., Qian Q., Ronco P., Rosner M. H., Trepiccione F., Viggiano D., Zoccali C., Capasso G., Akitaka A., Alahoti A., Alexander T. R., Altucci L., Amer H., Barone V., Biancone L., Bonventre J. V., Camussi G., Ciardiello F., Caraglia M., Carteni G., Cervantes A., Citterio F., Cosmai L., Daniele B., D'Errico A., De Vita F., Ereditato A., Falco G., Fouque D., Franco R., Gallieni M., Gambaro G., Kuo C., Launay-Vacher V., Maiello E., Mallamaci F., Malysxko J., Marino G., Martinelli E., Matarese G., Matsubara T., Messa P., Messina C., Mirone V., Morgillo F., Costa A. N., Orditura M., Pani A., Perna A., Pisano C., Pitts T., Porta C., Procopio G., Remuzzi G., Russo D., Siu L. L., Stadler W., Troiani T., Weisz A., Wiecek A., Xiaoqiang D., Zecchino O.

المساهمون: A. Capasso, A. Benigni, U. Capitanio, F.R. Danesh, V. Di Marzo, L. Gesualdo, G. Grandaliano, E.A. Jaime, J. Malyszko, M.A. Perazella, Q. Qian, P. Ronco, M.H. Rosner, F. Trepiccione, D. Viggiano, C. Zoccali, G. Capasso, A. Akitaka, A. Alahoti, T.R. Alexander, L. Altucci, H. Amer, V. Barone, L. Biancone, J.V. Bonventre, G. Camussi, F. Ciardiello, M. Caraglia, G. Carteni, A. Cervante, F. Citterio, L. Cosmai, B. Daniele, A. D'Errico, F. De Vita, A. Ereditato, G. Falco, D. Fouque, R. Franco, M. Gallieni, G. Gambaro, C. Kuo, V. Launay-Vacher, E. Maiello, F. Mallamaci, J. Malysxko, G. Marino, E. Martinelli, G. Matarese, T. Matsubara, P. Messa, C. Messina, V. Mirone, F. Morgillo, A.N. Costa, M. Orditura, A. Pani, A. Perna, C. Pisano, T. Pitt, C. Porta, G. Procopio, G. Remuzzi, D. Russo, L.L. Siu, W. Stadler, T. Troiani, A. Weisz, A. Wiecek, D. Xiaoqiang, O. Zecchino

مصطلحات موضوعية: acute kidney injury, cancer, chemotherapy, chronic kidney disease, nephrotoxicity, renal cell carcinoma, Settore MED/14 - Nefrologia, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31445584; info:eu-repo/semantics/altIdentifier/wos/WOS:000482187800009; International Conference on Onco-Nephrology; volume:96; issue:3; firstpage:555; lastpage:567; numberofpages:13; journal:KIDNEY INTERNATIONAL; http://hdl.handle.net/2434/674370Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070632078

الإتاحة: https://doi.org/10.1016/j.kint.2019.04.043Test
http://hdl.handle.net/2434/674370Test

المؤلفون: Poto R., Troiani T., Criscuolo G., Marone G., Ciardiello F., Tocchetti C. G., Varricchi G.

المساهمون: Poto, R., Troiani, T., Criscuolo, G., Marone, G., Ciardiello, F., Tocchetti, C. G., Varricchi, G.

مصطلحات موضوعية: cancer, cytotoxic T lymphocyte-associated protein (CTLA-4), immune checkpoint inhibitor (ICI), immune-related adverse event (irAE), immunotherapy, PD-L1, programmed cell death protein -1 (PD-1), B7-H1 Antigen, Human, Immune Checkpoint Inhibitor, Ligand, Retrospective Studie, Coliti, Pneumonia

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35432346; info:eu-repo/semantics/altIdentifier/wos/WOS:000783968500001; volume:13; firstpage:804597; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/11591/469896Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85128424455

الإتاحة: https://doi.org/10.3389/fimmu.2022.804597Test
http://hdl.handle.net/11591/469896Test

المؤلفون: Ameri, P, Canepa, M, Anker, MS, Belenkov, Y, Bergler-Klein, J, Cohen-Solal, A, Farmakis, D, López-Fernández, T, Lainscak, M, Pudil, R, Ruschitska, F, Seferovic, P, Filippatos, G, Coats, A, Suter, T, Von Haehling, S, Ciardiello, F, De Boer, RA, Lyon, AR, Tocchetti, CG, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology

المساهمون: Ameri, Pietro, Canepa, Marco, Anker, Markus S., Belenkov, Yury, Bergler-Klein, Jutta, Cohen-Solal, Alain, Farmakis, Dimitrio, López-Fernández, Teresa, Lainscak, Mitja, Pudil, Radek, Ruschitska, Frank, Seferovic, Petar, Filippatos, Gerasimo, Coats, Andrew, Suter, Thoma, Von Haehling, Stephan, Ciardiello, Fortunato, de Boer, Rudolf A., Lyon, Alexander R., Tocchetti, Carlo G.

المصدر: European Journal of Heart Failure. 20(5):879-887

مصطلحات موضوعية: Cardiac & Cardiovascular Systems, medicine.medical_treatment, Co-morbidity, Comorbidity, 030204 cardiovascular system & hematology, Global Health, Targeted therapy, Androgen deprivation therapy, Prostate cancer, 0302 clinical medicine, TARGETED THERAPY, RENAL-CELL CARCINOMA, Neoplasms, Epidemiology, INCREASED RISK, AMERICAN SOCIETY, Cancer, Heart failure, Prognosis, Therapy, Cardiology and Cardiovascular Medicine, ORAL ANTICOAGULANTS, Incidence (epidemiology), Incidence, Disease Management, 3. Good health, PROSTATE-CANCER, Survival Rate, PRACTICE GUIDELINES, 030220 oncology & carcinogenesis, Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology, Life Sciences & Biomedicine, Diagnostic Imaging, medicine.medical_specialty, Prognosi, LONG-TERM, Malignancy, 1102 Cardiovascular Medicine And Haematology, 03 medical and health sciences, Breast cancer, medicine, Humans, BREAST-CANCER, Intensive care medicine, TERM-FOLLOW-UP, EUROPEAN ASSOCIATION, Science & Technology, business.industry, medicine.disease, MYOCARDIAL-INFARCTION, Cardiovascular System & Hematology, ATRIAL-FIBRILLATION, Cardiovascular System & Cardiology, ANDROGEN DEPRIVATION THERAPY, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ae5221f0ca1c551bc118d061e00b74Test
https://hdl.handle.net/11370/4cad5946-19a3-4022-8749-fb5e2127683fTest

المؤلفون: Papaccio F, Della Corte CM, Viscardi G, Di Liello R, Esposito G, Sparano F, Ciardiello F, Morgillo F.

المساهمون: Papaccio, F, Della Corte, Cm, Viscardi, G, Di Liello, R, Esposito, G, Sparano, F, Ciardiello, F, Morgillo, F.

مصطلحات موضوعية: Cancer, HGF, Immune system, Immunotherapy, MET

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30441809; info:eu-repo/semantics/altIdentifier/wos/WOS:000451528500311; volume:19(11); firstpage:1; lastpage:13; numberofpages:13; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/11386/4752909Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85056631100; https://www.mdpi.com/1422-0067/19/11/3595Test

الإتاحة: https://doi.org/10.3390/ijms19113595Test
https://hdl.handle.net/11386/4752909Test
https://www.mdpi.com/1422-0067/19/11/3595Test

المؤلفون: Popescu, R. A., Schäfer, R., Califano, R., Eckert, R., Coleman, R., Douillard, J.-Y., Cervantes, A., Casali, Paolo G., Sessa, Cristiana, Cutsem, E. van, Vries, Elisabeth G. E. de, Pavlidis, Nicholas, Fumasoli, K., Wörmann, B., Samonigg, H., Cascinu, S., Hernández, J. J. C., Howard, A. J., Ciardiello, F., Stahel, R. A., Piccart, M.

المساهمون: Popescu, Ra, Schäfer, R, Califano, R, Eckert, R, Coleman, R, Douillard, Jy, Cervantes, A, Casali, Pg, Sessa, C, Van Cutsem, E, de Vries, E, Pavlidis, N, Fumasoli, K, Wörmann, B, Samonigg, H, Cascinu, S, Cruz Hernández, Jj, Howard, Aj, Ciardiello, Fortunato, Stahel, Ra, Piccart, M., Popescu, R. A., Schäfer, R., Califano, R., Eckert, R., Coleman, R., Douillard, J. -Y., Cervantes, A., Casali, P. G., Sessa, C., van Cutsem, E., de Vries, E., Pavlidis, N., Fumasoli, K., Wörmann, B., Samonigg, H., Cascinu, S., Hernández, J. J. Cruz, Howard, A. J., Ciardiello, F., Stahel, R. A., University of Zurich, Popescu, R A, Pavlidis, Nicholas [0000-0002-2195-9961], Guided Treatment in Optimal Selected Cancer Patients (GUTS)

المصدر: Annals of Oncology
Annals of Oncology, 25(1), 9-15. Oxford University Press

مصطلحات موضوعية: Oncology, Political participation, Work environment, diagnosis, 2720 Hematology, Cancer prevention, Profession, Continuing medical education, Neoplasms, Health care, Diagnosis, Drug use, Priority journal, Evidence-Based Medicine, Cost effectiveness analysis, treatment, Medical oncologist, Professional development, Professional standard, Cancer diagnosis, Hematology, Professional practice, medical oncology, Europe, Patient safety, 2730 Oncology, Multidisciplinary team (MDT), multidisciplinary team (MDT), Diagnosi, Human, Quality of life, Medical education, medicine.medical_specialty, Medical oncology, education, Specialty, Translational research, 610 Medicine & health, Cancer research, Patient care, Article, Research, Treatment, Humans, Interdisciplinary Communication, Medical Oncology, Physician-Patient Relations, Quality of Health Care, Physician's Role, Nursing, Internal medicine, medicine, profession, research, Physician-Patient Relation, business.industry, Physician attitude, Cancer, Evidence-based medicine, Physician-patient relations, medicine.disease, Personalized medicine, Family medicine, Evidence based medicine, 10032 Clinic for Oncology and Hematology, Position paper, Cancer patient, Neoplasm, business

وصف الملف: Popescu et al_AoO_2014.pdf - application/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a972dbf1a5f90b570901fdde6bf09f0eTest
https://research.rug.nl/en/publications/d88c96b3-7f18-4463-ab46-c33e7ef4b95cTest

المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test

المؤلفون: Cutsem, E. Van, Dicato, M., Arber, N., Berlin, J., Cervantes, A., Ciardiello, F., Gramont, A. De, Diaz-Rubio, E., Ducreux, M., Geva, R., Glimelius, B., Glynne-Jones, R., Grothey, Axel, Gruenberger, T., Haller, D., Haustermans, K., Labianca, R., Lenz, H. J., Minsky, B., Nordlinger, B., Ohtsu, A., Pavlidis, Nicholas, Rougier, P., Schmiegel, W., Velde, C. Van de, Schmoll, H. J., Sobrero, A., Tabernero, Josep

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961]

المصدر: Annals of Oncology : Official Journal of the European Society for Medical Oncology / ESMO

مصطلحات موضوعية: Oncology, Colorectal cancer, medicine.medical_treatment, Braf protein, Gastroenterology, Metastasis, Drug antagonism, Targeted therapy, Antineoplastic agents, Pathology, Conference paper, Biological markers, Predictive marker, Hematology, Prognosis, Chemotherapy regimen, Antineoplastic agent, Proto-oncogene proteins, Ras protein, Human, Receptor, medicine.medical_specialty, Neoplasm metastasis, Ras proteins, MEDLINE, Oncoprotein, Colorectal neoplasms, Proto-oncogene proteins b-raf, Internal medicine, Genetics, medicine, Humans, Gastrointestinal cancer, Colorectal tumor, B raf kinase, Epidermal growth factor receptor, Kras protein, business.industry, Epidermal growth factor, Cancer, medicine.disease, digestive system diseases, Biological marker, Metabolism, Spain, Mutation, Carcinoembryonic antigen, Microsatellite instability, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbacd7b9ee1ebf6fa145eb7d60aaa564Test
https://doi.org/10.1093/annonc/mdq273Test

المؤلفون: Normanno N, Pinto C, Castiglione F, Bardelli A, Gambacorta M, Botti G, Nappi O, Siena S, Ciardiello F, Taddei G, MARCHETTI, Antonio

المساهمون: Normanno, N, Pinto, C, Castiglione, F, Bardelli, A, Gambacorta, M, Botti, G, Nappi, O, Siena, S, Ciardiello, F, Taddei, G, Marchetti, Antonio

مصطلحات موضوعية: 1ST-LINE TREATMENT, PHASE-III, CANCER, CETUXIMAB, FLUOROURACIL, LEUCOVORIN, PANITUMUMAB, OXALIPLATIN, IRINOTECAN, EFFICACY

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22216189; info:eu-repo/semantics/altIdentifier/wos/WOS:000299113600058; volume:6; issue:12; firstpage:1; lastpage:6; numberofpages:6; journal:PLOS ONE; http://hdl.handle.net/11564/229407Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-83755174239; http://www.ncbi.nlm.nih.gov/pubmed/22216189Test; http://www.plosone.org/article/info:doi/10.1371/journal.pone.0029146Test; http://www.scopus.com/record/display.url?eid=2-s2.0-83755174239&origin=resultslist&sort=plfTest-f&src=s&sid=B96543A7BDE7AF9F0255EDEB99C1FE78.aXczxbyuHHiXgaIW6Ho7g%3a1170&sot=aut&sdt=a&sl=38&s=AU-ID%28%22Marchetti%2c+Antonio%22+7102878291%29&relpos=6&relpos=6&searchTerm=AU-ID%28%5C%26quot%3BMarchetti,+Antonio%5C%26quot%3B+7102878291%29

الإتاحة: https://doi.org/10.1371/journal.pone.0029146Test
http://hdl.handle.net/11564/229407Test
http://www.ncbi.nlm.nih.gov/pubmed/22216189Test
http://www.scopus.com/record/display.url?eid=2-s2.0-83755174239&origin=resultslist&sort=plfTest-f&src=s&sid=B96543A7BDE7AF9F0255EDEB99C1FE78.aXczxbyuHHiXgaIW6Ho7g%3a1170&sot=aut&sdt=a&sl=38&s=AU-ID%28%22Marchetti%2c+Antonio%22+7102878291%29&relpos=6&relpos=6&searchTerm=AU-ID%28%5C%26quot%3BMarchetti,+Antonio%5C%26quot%3B+7102878291%29

المؤلفون: Martinelli, E., De Palma, R., Orditura, M., De Vita, F., Ciardiello, F.

المصدر: Clinical & Experimental Immunology; Oct2009, Vol. 158 Issue 1, p1-9, 9p, 2 Diagrams, 3 Charts

مصطلحات موضوعية: CANCER treatment, IMMUNOGLOBULINS, EPIDERMAL growth factor, MONOCLONAL antibodies